Angela Dispenzieri, M.D., is a consultant in the Division of Hematology, Department of Internal Medicine at Mayo Clinic. She has joint appointments in the Division of Clinical Biochemistry and Immunology, Department of Laboratory Medicine and Pathology, and the Department of Molecular Medicine. Dr. Dispenzieri holds the academic rank of Professor of Medicine and of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, and she is recognized with the distinction of a named professorship, the Serene M. and Frances C. Durling Professorship. She joined the staff of Mayo Clinic in 1998 and served as Chair of Hematology Research from 2014 to 2022. She currently chairs the Mayo Clinic Amyloid Interest Group.

Dr. Dispenzieri earned her B.S. in biology at the Massachusetts Institute of Technology and her M.D. at Albert Einstein College of Medicine. She subsequently completed a residency and a fellowship in Hematology and Oncology at Mayo Clinic.

Dr. Dispenzieri conducts research in plasma cell disorders, including multiple myeloma, amyloidosis, POEMS syndrome and other rare plasma cell disorders. Her joint appointments in Hematology and Clinical Chemistry are conducive to clinical and translational research in these fields. She also specializes in clinical trials and stem cell transplantation. She is the Director of the Biospecimens Core of the Mayo Clinic Myeloma SPORE. Dr. Dispenzieri is frequently invited to give presentations on her research both domestically and internationally, and she has held editorial and reviewer responsibilities for several prominent publications. She has been an author or co-author on over 600 journal articles, book chapters, and abstracts in the field of plasma cell disorders, including multiple myeloma, immunoglobulin light chain amyloidosis, POEMS syndrome, Castleman Disease, and mass spectrometry techniques.

She has had leadership roles in international amyloid and myeloma societies including being a past treasurer and past president of the International Society of Amyloidosis and past treasurer for the International Myeloma Society. She is President of the International Kidney and Monoclonal Gammopathy Society. She is intimately involved with patient education and advocacy groups like the Amyloid Research Consortium and Amyloid Support Groups.

In addition to her clinical and research activities, Dr. Dispenzieri is active in education and provides mentorship to many residents and fellows.